Press release (June 23rd 2009):
BioSante Pharmaceuticals Announces Elestrin™ NDA Submission in Israel

Press release (March 17th 2009):
PharmaSwiss SA Signed Marketing Agreement for Once-Daily Extended Release Muscle Relaxant with Eurand for Israel

Press release (December 8th 2008):
BioSante Pharmaceuticals Signs Elestrin™ Marketing Agreement with PharmaSwiss SA for Israel

Presentation (September 25th 2008):
UBS Global Life Sciences Conference, New York City

Press release (May 20th 2008):
Enterprise Investors Invests in PharmaSwiss SA

Press release (July 10th 2007):
PharmaSwiss S.A. expands shareholder base